Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Protox initiates dosing in phase II clinical trial of PRX-302 in BPH

May 19, 2008

AEterna Zentaris initiates dosing in phase III safety trial of cetrorelix in BPH

May 16, 2008

Recent Astellas patent describes new compounds for treating urinary incontinence

May 14, 2008

BMP receives SFDA acceptance for Enablex clinical trial

May 9, 2008

Nymox announces that 3 year follow-up study of NX-1207 for BPH is near completion

May 8, 2008

Orexo reports results from phase I study of OX-19 nasal spray for incontinence

April 30, 2008

Spectrum reports positive results from phase IIb study of LHRH antagonist ozarelix in BPH

April 28, 2008

Combination of dutasteride with tamsulosin approved for the treatment of BPH

April 24, 2008

Novel agents for treating urinary incontinence disclosed in recent Fujiyakuhin patent

April 23, 2008

AEterna completes recruitment for first phase III cetrorelix trial in BPH

April 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...